129 related articles for article (PubMed ID: 10021455)
1. Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit.
Chan JC; Carmeliet P; Moons L; Rosen ED; Huang ZF; Broze GJ; Collen D; Castellino FJ
J Clin Invest; 1999 Feb; 103(4):475-82. PubMed ID: 10021455
[TBL] [Abstract][Full Text] [Related]
2. Gene targeting in hemostasis. tissue factor pathway inhibitor.
Chan JC
Front Biosci; 2001 Feb; 6():D216-21. PubMed ID: 11171546
[TBL] [Abstract][Full Text] [Related]
3. Combined factor VII/protein C deficiency results in intrauterine coagulopathy in mice.
Chan JC; Cornelissen I; Collen D; Ploplis VA; Castellino FJ
J Clin Invest; 2000 Apr; 105(7):897-903. PubMed ID: 10749569
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.
Huang ZF; Higuchi D; Lasky N; Broze GJ
Blood; 1997 Aug; 90(3):944-51. PubMed ID: 9242522
[TBL] [Abstract][Full Text] [Related]
5. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding.
Rosen ED; Chan JC; Idusogie E; Clotman F; Vlasuk G; Luther T; Jalbert LR; Albrecht S; Zhong L; Lissens A; Schoonjans L; Moons L; Collen D; Castellino FJ; Carmeliet P
Nature; 1997 Nov; 390(6657):290-4. PubMed ID: 9384381
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor pathway inhibitor gene disruption.
Broze GJ
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S89-92. PubMed ID: 9819035
[TBL] [Abstract][Full Text] [Related]
7. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
[TBL] [Abstract][Full Text] [Related]
8. Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s).
Furlan Freguia C; Toso R; Pollak ES; Arruda VR; Pinotti M; Bernardi F
Haematologica; 2004 Dec; 89(12):1504-9. PubMed ID: 15590402
[TBL] [Abstract][Full Text] [Related]
9. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice.
Pedersen B; Holscher T; Sato Y; Pawlinski R; Mackman N
Blood; 2005 Apr; 105(7):2777-82. PubMed ID: 15598816
[TBL] [Abstract][Full Text] [Related]
10. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor-dependent pathway in severe preeclampsia revisited: a Brazilian cohort study.
Dusse LM; Godoi LC; Gomes KB; Carvalho Md; Lwaleed BA
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):436-40. PubMed ID: 26765308
[TBL] [Abstract][Full Text] [Related]
12. Mutations of TFPI-binding exosites on factor VII cause bleeding phenotypes in factor VII deficiency.
Seanoon K; Payongsri P; Vivithanaporn P; Sirachainan N; Chuansumrit A; Hongeng S; Tanratana P
Blood Adv; 2022 Nov; 6(22):5887-5897. PubMed ID: 35973191
[TBL] [Abstract][Full Text] [Related]
13. Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes.
Girolami A; Bertozzi I; de Marinis GB; Bonamigo E; Fabris F
Hematology; 2011 Sep; 16(5):308-12. PubMed ID: 21902896
[TBL] [Abstract][Full Text] [Related]
14. Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency.
Tran HT; Tjønnfjord GE; Holme PA
Haemophilia; 2014 Jan; 20(1):141-6. PubMed ID: 23992369
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. possible implications for measurements in vivo after heparin therapy.
Bladbjerg EM; Larsen LF; Ostergaard P; Jespersen J
Blood Coagul Fibrinolysis; 2000 Dec; 11(8):739-45. PubMed ID: 11132652
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis in a patient with severe factor VII deficiency and an inhibitor: report of a novel mutation (S103G).
Pruthi RK; Rodriguez V; Allen C; Slaby JA; Schmidt KA; Plumhoff EA
Eur J Haematol; 2007 Oct; 79(4):354-9. PubMed ID: 17692102
[TBL] [Abstract][Full Text] [Related]
17. Two naturally occurring mutations on FVII gene (S363I-W364C) altering intrinsic catalytic activity.
Peyvandi F; De Cristofaro R; Akhavan S; Carew JA; Landolfi R; Bauer KA; Mannucci PM
Thromb Haemost; 2002 Nov; 88(5):750-5. PubMed ID: 12428089
[TBL] [Abstract][Full Text] [Related]
18. [Molecular analysis of two pedigrees with inherited coagulation factor VII deficiency].
Liang WL; Wei HY; Lin FQ; Zhou JL
Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):817-20. PubMed ID: 23302610
[TBL] [Abstract][Full Text] [Related]
19. The Story of Serum Prothrombin Conversion Accelerator, Proconvertin, Stable Factor, Cothromboplastin, Prothrombin Accelerator or Autoprothrombin I, and Their Subsequent Merging into Factor VII.
Girolami A; Cosi E; Santarossa C; Ferrari S; Luigia Randi M
Semin Thromb Hemost; 2015 Jun; 41(4):366-73. PubMed ID: 25973586
[TBL] [Abstract][Full Text] [Related]
20. [Novel double heterozygous mutations on Met306Val and Thr181Asn related to a hereditary coagulation factor VII deficiency].
Tu CQ; Deng CY; Wu JZ; Pan CY; Xie CY
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):124-7. PubMed ID: 16620721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
